121 related articles for article (PubMed ID: 22116343)
1. Frailties in multi-state models: Are they identifiable? Do we need them?
Putter H; van Houwelingen HC
Stat Methods Med Res; 2015 Dec; 24(6):675-92. PubMed ID: 22116343
[TBL] [Abstract][Full Text] [Related]
2. A simulation procedure based on copulas to generate clustered multi-state survival data.
Rotolo F; Legrand C; Van Keilegom I
Comput Methods Programs Biomed; 2013 Mar; 109(3):305-12. PubMed ID: 23099295
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of nested frailties into semiparametric multi-state models.
Rotolo F; Rondeau V; Legrand C
Stat Med; 2016 Feb; 35(4):609-21. PubMed ID: 26381148
[TBL] [Abstract][Full Text] [Related]
4. Prediction of the long-term survival in breast cancer patients according to the present oncological status.
Hatteville L; Mahe C; Hill C
Stat Med; 2002 Aug; 21(16):2345-54. PubMed ID: 12210619
[TBL] [Abstract][Full Text] [Related]
5. Estimation and prediction in a multi-state model for breast cancer.
Putter H; van der Hage J; de Bock GH; Elgalta R; van de Velde CJ
Biom J; 2006 Jun; 48(3):366-80. PubMed ID: 16845902
[TBL] [Abstract][Full Text] [Related]
6. tdc.msm: an R library for the analysis of multi-state survival data.
Meira-Machado L; Cadarso-Suárez C; de Uña-Alvarez J
Comput Methods Programs Biomed; 2007 May; 86(2):131-40. PubMed ID: 17350136
[TBL] [Abstract][Full Text] [Related]
7. Time-varying coefficients in a multivariate frailty model: Application to breast cancer recurrences of several types and death.
Mazroui Y; Mauguen A; Mathoulin-Pélissier S; MacGrogan G; Brouste V; Rondeau V
Lifetime Data Anal; 2016 Apr; 22(2):191-215. PubMed ID: 25944225
[TBL] [Abstract][Full Text] [Related]
8. Dynamic frailty models based on compound birth-death processes.
Putter H; van Houwelingen HC
Biostatistics; 2015 Jul; 16(3):550-64. PubMed ID: 25681608
[TBL] [Abstract][Full Text] [Related]
9. Recurrence in breast cancer. Analysis with frailty model.
Gohari MR; Mahmoudi M; Mohammed K; Pasha E; Khodabakhshi R
Saudi Med J; 2006 Aug; 27(8):1187-93. PubMed ID: 16883450
[TBL] [Abstract][Full Text] [Related]
10. Multi-state model for studying an intermediate event using time-dependent covariates: application to breast cancer.
Meier-Hirmer C; Schumacher M
BMC Med Res Methodol; 2013 Jun; 13():80. PubMed ID: 23786493
[TBL] [Abstract][Full Text] [Related]
11. Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients.
de Glas NA; Kiderlen M; Vandenbroucke JP; de Craen AJ; Portielje JE; van de Velde CJ; Liefers GJ; Bastiaannet E; Le Cessie S
J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26614095
[TBL] [Abstract][Full Text] [Related]
12. A joint frailty model for survival and gap times between recurrent events.
Huang X; Liu L
Biometrics; 2007 Jun; 63(2):389-97. PubMed ID: 17688491
[TBL] [Abstract][Full Text] [Related]
13. Multi-state models for the analysis of time-to-event data.
Meira-Machado L; de Uña-Alvarez J; Cadarso-Suárez C; Andersen PK
Stat Methods Med Res; 2009 Apr; 18(2):195-222. PubMed ID: 18562394
[TBL] [Abstract][Full Text] [Related]
14. Assessing gamma frailty models for clustered failure time data.
Shih JH; Louis TA
Lifetime Data Anal; 1995; 1(2):205-20. PubMed ID: 9385102
[TBL] [Abstract][Full Text] [Related]
15. A Bayesian approach to competing risks analysis with masked cause of death.
Sen A; Banerjee M; Li Y; Noone AM
Stat Med; 2010 Jul; 29(16):1681-95. PubMed ID: 20575048
[TBL] [Abstract][Full Text] [Related]
16. Dispersion frailty models and HGLMs.
Noh M; Ha ID; Lee Y
Stat Med; 2006 Apr; 25(8):1341-54. PubMed ID: 16217839
[TBL] [Abstract][Full Text] [Related]
17. Prognosis following local recurrence after breast conserving treatment in young women with early breast cancer.
van der Sangen MJ; Poortmans PM; Scheepers SW; Lemaire BM; van Berlo CL; Tjan-Heijnen VC; Voogd AC
Eur J Surg Oncol; 2013 Aug; 39(8):892-8. PubMed ID: 23726902
[TBL] [Abstract][Full Text] [Related]
18. A Spatial Survival Model in Presence of Competing Risks for Iranian Gastrointestinal Cancer Patients.
Hesam S; Mahmoudi M; Rahimi Foroushani A; Yaseri M; Mansournia MA
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2947-2954. PubMed ID: 30362330
[TBL] [Abstract][Full Text] [Related]
19. A systematic model specification procedure for an illness-death model without recovery.
Eulenburg C; Mahner S; Woelber L; Wegscheider K
PLoS One; 2015; 10(4):e0123489. PubMed ID: 25874628
[TBL] [Abstract][Full Text] [Related]
20. Estimates of clinically useful measures in competing risks survival analysis.
Ambrogi F; Biganzoli E; Boracchi P
Stat Med; 2008 Dec; 27(30):6407-25. PubMed ID: 18937229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
